Long-term use of aspirin and the risk of gastrointestinal bleeding

American Journal of Medicine

Volumn 124, Issue 5, 2011, Pages 426-433

  Huang, Edward S ^a   Strate, Lisa L ^b   Ho, Wendy W ^c   Lee, Salina S ^d   Chan, Andrew T ^a,e  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d NORTHWESTERN UNIVERSITY   (United States)

^e HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Aspirin; Dose; Duration; Gastrointestinal bleeding; Long term

Indexed keywords

ACETYLSALICYLIC ACID; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; ARTHRITIS; ARTICLE; BLOOD TRANSFUSION; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; DOSE RESPONSE; DRUG USE; FEMALE; FOLLOW UP; GASTROINTESTINAL HEMORRHAGE; HEADACHE; HOSPITALIZATION; HUMAN; LONG TERM CARE; LOWER GASTROINTESTINAL BLEEDING; MAJOR CLINICAL STUDY; MALE; MUSCULOSKELETAL PAIN; NURSE; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUESTIONNAIRE; RISK FACTOR; TABLET; TREATMENT DURATION; UPPER GASTROINTESTINAL BLEEDING;

ADULT; AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; CYCLOOXYGENASE INHIBITORS; DRUG ADMINISTRATION SCHEDULE; FEMALE; FIBRINOLYTIC AGENTS; FOLLOW-UP STUDIES; GASTROINTESTINAL HEMORRHAGE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; PROSPECTIVE STUDIES; RISK ASSESSMENT; TIME FACTORS;

EID: 79955641250     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjmed.2010.12.022     Document Type: Article

References (45)

1. Aspirin for the prevention of cardiovascular disease: U.S. Preventive Services Task Force recommendation statement Ann Intern Med 150 2009 396 404
2. T.A. Pearson, S.N. Blair, and S.R. Daniels AHA Guidelines for Primary Prevention of Cardiovascular Disease and Stroke: 2002 Update: Consensus Panel Guide to Comprehensive Risk Reduction for Adult Patients Without Coronary or Other Atherosclerotic Vascular Diseases American Heart Association Science Advisory and Coordinating Committee Circulation 106 2002 388 391 (Pubitemid 34778969)
3. Steering Committee of the Physicians' Health Study Research Group Final report on the aspirin component of the ongoing Physicians' Health Study N Engl J Med 321 1989 129 135
4. Thrombosis prevention trial: randomised trial of low-intensity oral anticoagulation with warfarin and low-dose aspirin in the primary prevention of ischaemic heart disease in men at increased risk The Medical Research Council's General Practice Research Framework Lancet 351 1998 233 241
5. L. Hansson, A. Zanchetti, and S.G. Carruthers Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial HOT Study Group Lancet 351 1998 1755 1762 (Pubitemid 28269185)
6. G. de Gaetano Low-dose aspirin and vitamin E in people at cardiovascular risk: a randomised trial in general practice Collaborative Group of the Primary Prevention Project Lancet 357 2001 89 95
7. S. Juul-Moller, N. Edvardsson, B. Jahnmatz, A. Rosen, S. Sorensen, and R. Omblus Double-blind trial of aspirin in primary prevention of myocardial infarction in patients with stable chronic angina pectoris The Swedish Angina Pectoris Aspirin Trial (SAPAT) Group Lancet 340 1992 1421 1425
8. S. Derry, and Y.K. Loke Risk of gastrointestinal haemorrhage with long term use of aspirin: meta-analysis BMJ 321 2000 1183 1187
9. K.R. McQuaid, and L. Laine Systematic review and meta-analysis of adverse events of low-dose aspirin and clopidogrel in randomized controlled trials Am J Med 119 2006 624 638 (Pubitemid 44128438)
10. V.L. Serebruany, S.R. Steinhubl, and P.B. Berger Analysis of risk of bleeding complications after different doses of aspirin in 192,036 patients enrolled in 31 randomized controlled trials Am J Cardiol 95 2005 1218 1222 (Pubitemid 40616424)
11. P.M. Ridker, N.R. Cook, and I.M. Lee A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women N Engl J Med 352 2005 1293 1304
12. J. Hallas, M. Dall, and A. Andries Use of single and combined antithrombotic therapy and risk of serious upper gastrointestinal bleeding: population based case-control study BMJ 333 2006 726
13. J. Slattery, C.P. Warlow, C.J. Shorrock, and M.J. Langman Risks of gastrointestinal bleeding during secondary prevention of vascular events with aspirinanalysis of gastrointestinal bleeding during the UK-TIA trial Gut 37 1995 509 511
14. P. Serrano, A. Lanas, M.T. Arroyo, and I.J. Ferreira Risk of upper gastrointestinal bleeding in patients taking low-dose aspirin for the prevention of cardiovascular diseases Aliment Pharmacol Ther 16 2002 1945 1953
15. W.C. Willett, L. Sampson, and M.J. Stampfer Reproducibility and validity of a semiquantitative food frequency questionnaire Am J Epidemiol 122 1985 51 65 (Pubitemid 15010435)
16. G.A. Colditz, J.E. Manson, and S.E. Hankinson The Nurses' Health Study: 20-year contribution to the understanding of health among women J Womens Health 6 1997 49 62
17. A.T. Chan, E.L. Giovannucci, and E.S. Schernhammer A prospective study of aspirin use and the risk for colorectal adenoma Ann Intern Med 140 2004 157 166
18. G.C. Curhan, E.L. Knight, B. Rosner, S.E. Hankinson, and M.J. Stampfer Lifetime nonnarcotic analgesic use and decline in renal function in women Arch Intern Med 164 2004 1519 1524 (Pubitemid 38970471)
19. J.E. Manson, M.J. Stampfer, and G.A. Colditz A prospective study of aspirin use and primary prevention of cardiovascular disease in women JAMA 266 1991 521 527
20. D.M. Jensen, G.A. Machicado, R. Jutabha, and T.O. Kovacs Urgent colonoscopy for the diagnosis and treatment of severe diverticular hemorrhage N Engl J Med 342 2000 78 82 (Pubitemid 30036598)
21. F.B. Hu, M.J. Stampfer, and E. Rimm Dietary fat and coronary heart disease: a comparison of approaches for adjusting for total energy intake and modeling repeated dietary measurements Am J Epidemiol 149 1999 531 540 (Pubitemid 29130020)
22. A.T. Chan, E.L. Giovannucci, and J.A. Meyerhardt Long-term use of aspirin and nonsteroidal anti-inflammatory drugs and risk of colorectal cancer JAMA 294 2005 914 923 (Pubitemid 41215460)
23. A.T. Chan, S. Ogino, and C.S. Fuchs Aspirin and the risk of colorectal cancer in relation to the expression of COX-2 N Engl J Med 356 2007 2131 2142 (Pubitemid 47010839)
24. I.B. Andersen, T. Jorgensen, O. Bonnevie, M. Gronbaek, and T.I. Sorensen Smoking and alcohol intake as risk factors for bleeding and perforated peptic ulcers: a population-based cohort study Epidemiology 11 2000 434 439 (Pubitemid 30428937)
25. D.L. Bhatt, J. Scheiman, and N.S. Abraham ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents Circulation 118 2008 1894 1909
26. M. Pahor, J.M. Guralnik, and M.E. Salive Physical activity and risk of severe gastrointestinal hemorrhage in older persons JAMA 272 1994 595 599 (Pubitemid 24255217)
27. L.L. Strate, Y.L. Liu, W.H. Aldoori, and E.L. Giovannucci Physical activity decreases diverticular complications Am J Gastroenterol 104 2009 1221 1230
28. L.L. Strate, Y.L. Liu, W.H. Aldoori, S. Syngal, and E.L. Giovannucci Obesity increases the risks of diverticulitis and diverticular bleeding Gastroenterology 136 2009 115 e1 122 e1
29. A.T. Cole, N. Hudson, and L.C. Liew Protection of human gastric mucosa against aspirin-enteric coating or dose reduction? Aliment Pharmacol Ther 13 1999 187 193 (Pubitemid 29090014)
30. P.S. Penglis, L.G. Cleland, M. Demasi, G.E. Caughey, and M.J. James Differential regulation of prostaglandin E2 and thromboxane A2 production in human monocytes: implications for the use of cyclooxygenase inhibitors J Immunol 165 2000 1605 1611 (Pubitemid 30604598)
31. R.J. Peters, S.R. Mehta, and K.A. Fox Effects of aspirin dose when used alone or in combination with clopidogrel in patients with acute coronary syndromes: observations from the Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) study Circulation 108 2003 1682 1687 (Pubitemid 37243654)
32. E. Smecuol, J.C. Bai, and E. Sugai Acute gastrointestinal permeability responses to different non-steroidal anti-inflammatory drugs Gut 49 2001 650 655 (Pubitemid 32989201)
33. A. Lanas, and F. Sopena Nonsteroidal anti-inflammatory drugs and lower gastrointestinal complications Gastroenterol Clin North Am 38 2009 333 352
34. I. Bjarnason, J. Hayllar, A.J. MacPherson, and A.S. Russell Side effects of nonsteroidal anti-inflammatory drugs on the small and large intestine in humans Gastroenterology 104 1993 1832 1847 (Pubitemid 23235480)
35. B.K. Reuter, N.M. Davies, and J.L. Wallace Nonsteroidal anti-inflammatory drug enteropathy in rats: role of permeability, bacteria, and enterohepatic circulation Gastroenterology 112 1997 109 117 (Pubitemid 27008992)
36. B. Cryer, and M. Feldman Effects of very low dose daily, long-term aspirin therapy on gastric, duodenal, and rectal prostaglandin levels and on mucosal injury in healthy humans Gastroenterology 117 1999 17 25 (Pubitemid 29297615)
37. A. Lanas, M.C. Sekar, and B.I. Hirschowitz Objective evidence of aspirin use in both ulcer and nonulcer upper and lower gastrointestinal bleeding Gastroenterology 103 1992 862 869
38. D.A. Peura, F.L. Lanza, C.J. Gostout, and P.G. Foutch The American College of Gastroenterology Bleeding Registry: preliminary findings Am J Gastroenterol 92 1997 924 928 (Pubitemid 27237578)
39. H.D. Lewis Jr, J.W. Davis, and D.G. Archibald Protective effects of aspirin against acute myocardial infarction and death in men with unstable angina Results of a Veterans Administration Cooperative Study N Engl J Med 309 1983 396 403 (Pubitemid 13033964)
40. A. Meijer, F.W. Verheugt, C.J. Werter, K.I. Lie, J.M. van der Pol, and M.J. van Eenige Aspirin versus coumadin in the prevention of reocclusion and recurrent ischemia after successful thrombolysis: a prospective placebo-controlled angiographic study Results of the APRICOT Study Circulation 87 1993 1524 1530 (Pubitemid 23133096)
41. The RISC Group Risk of myocardial infarction and death during treatment with low dose aspirin and intravenous heparin in men with unstable coronary artery disease Lancet 336 1990 827 830
42. H. Fischer, J.C. Becker, and P. Boknik Expression of endothelial cell-derived nitric oxide synthase (eNOS) is increased during gastric adaptation to chronic aspirin intake in humans Aliment Pharmacol Ther 13 1999 507 514 (Pubitemid 29176875)
43. J.W. Konturek, A. Dembinski, R. Stoll, W. Domschke, and S.J. Konturek Mucosal adaptation to aspirin induced gastric damage in humans Studies on blood flow, gastric mucosal growth, and neutrophil activation Gut 35 1994 1197 1204 (Pubitemid 24277330)
44. S. Hernandez-Diaz, and L.A. Rodriguez Association between nonsteroidal anti-inflammatory drugs and upper gastrointestinal tract bleeding/perforation: an overview of epidemiologic studies published in the 1990s Arch Intern Med 160 2000 2093 2099 (Pubitemid 30482713)
45. J.P. Kelly, D.W. Kaufman, J.M. Jurgelon, J. Sheehan, R.S. Koff, and S. Shapiro Risk of aspirin-associated major upper-gastrointestinal bleeding with enteric-coated or buffered product Lancet 348 1996 1413 1416 (Pubitemid 26395236)